Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Altered Expression of Histone Deacetylases in Cancer

Volume 20, Issue 1-2, 2015, pp. 19-34
DOI: 10.1615/CritRevOncog.2014012554
Get accessGet access

ABSTRACT

Epigenetic mechanisms, including histone deacetylation, are commonly deregulated in cancer. Histone deacetylases (HDACs) play an important role in tumorigenesis and their value as therapeutic targets has been under intense investigation in recent years. In addition to classical HDACs (HDAC classes I, II, and IV), sirtuins (class III HDACs) are currently in the spotlight of cancer research showing promise as cancer biomarkers and therapeutic targets. Translating research knowledge into the clinical setting is, however, a challenging and demanding task. This review describes the association between HDAC deregulation and cancer promotion and highlights recent advances in the use of HDAC inhibitors in the management of neoplastic diseases, with emphasis on urological tumors. Sirtuins' bivalent role in tumor development and therapeutic agents targeting these molecules will be also addressed.

CITED BY
  1. Bitzer M., Malek N.P., Personalized Epigenetics, in Medical Epigenetics, 2016. Crossref

  2. Yu Yang, Lowy Michelle Montag, Elble Randolph C., Tet-On lentiviral transductants lose inducibility when silenced for extended intervals in mammary epithelial cells, Metabolic Engineering Communications, 3, 2016. Crossref

  3. Wang Lihui, Bao Xuefei, Yang Jingyu, Li Huahuan, Zhou Qifan, Jiang Xiaorui, Li Meng, Liu Xing, Yuan Xiangzhong, Sun Yuhong, Chen Junli, Zhang Jingyuan, Chen Guoliang, Wu Chunfu, Novel cinnamohydroxamic acid derivatives as HDAC inhibitors with anticancer activity in vitro and in vivo, Chemico-Biological Interactions, 249, 2016. Crossref

  4. Witkin Steven S., Lactic acid alleviates stress: good for female genital tract homeostasis, bad for protection against malignancy, Cell Stress and Chaperones, 23, 3, 2018. Crossref

  5. Khan Faisal Saeed, Ali Ijaz, Afridi Ume Kalsoom, Ishtiaq Muhammad, Mehmood Rashid, Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics, Hepatology International, 11, 1, 2017. Crossref

  6. Sivaprakasam Sathish, Bhutia Yangzom, Ramachandran Sabarish, Ganapathy Vadivel, Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health, Nutrients, 9, 8, 2017. Crossref

  7. Guynn Jenna, Chan Elizabeth A. W., Zinc and Zinc-Dependent Proteins in Cancer and Chemotherapeutics, in Essential and Non-essential Metals, 2017. Crossref

  8. El Bairi Khalid, Tariq Kanwal, Himri Imane, Jaafari Abdeslam, Smaili Wiam, Kandhro Abdul Hafeez, Gouri Adel, Ghazi Bouchra, Decoding colorectal cancer epigenomics, Cancer Genetics, 220, 2018. Crossref

  9. Wang Shih-Wei, Chen Yun-Ru, Chow Jyh-Ming, Chien Ming-Hsien, Yang Shun-Fa, Wen Yu-Ching, Lee Wei-Jiunn, Tseng Tsui-Hwa, Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemia cells, Molecular Carcinogenesis, 57, 7, 2018. Crossref

  10. Kaletsch Aline, Pinkerneil Maria, Hoffmann Michèle J., Jaguva Vasudevan Ananda A., Wang Chenyin, Hansen Finn K., Wiek Constanze, Hanenberg Helmut, Gertzen Christoph, Gohlke Holger, Kassack Matthias U., Kurz Thomas, Schulz Wolfgang A., Niegisch Günter, Effects of novel HDAC inhibitors on urothelial carcinoma cells, Clinical Epigenetics, 10, 1, 2018. Crossref

  11. Akinshina A. I., Smirnova D. V., Zagainova A. V., Makarov V. V., Yudin S. M., Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease, Russian Journal of Gastroenterology, Hepatology, Coloproctology, 29, 2, 2019. Crossref

  12. Oltra Sara S., Cejalvo Juan Miguel, Tormo Eduardo, Albanell Marta, Ferrer Ana, Nacher Marta, Bermejo Begoña, Hernando Cristina, Chirivella Isabel, Alonso Elisa, Burgués Octavio, Peña-Chilet Maria, Eroles Pilar, Lluch Ana, Ribas Gloria, Martinez María Teresa, HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women, Cancers, 12, 2, 2020. Crossref

  13. Wang Chenyin, Hamacher Alexandra, Petzsch Patrick, Köhrer Karl, Niegisch Günter, Hoffmann Michèle J., Schulz Wolfgang A., Kassack Matthias U., Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1, Cancers, 12, 2, 2020. Crossref

  14. Hu Xue-ting, Xing Wei, Zhao Rong-sen, Tan Yan, Wu Xiao-feng, Ao Luo-quan, Li Zhan, Yao Meng-wei, Yuan Mu, Guo Wei, Li Shang-ze, Yu Jian, Ao Xiang, Xu Xiang, HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer, Journal of Experimental & Clinical Cancer Research, 39, 1, 2020. Crossref

  15. Cervello Melchiorre, Emma Maria R., Augello Giuseppa, Cusimano Antonella, Giannitrapani Lydia, Soresi Maurizio, Akula Shaw M., Abrams Stephen L., Steelman Linda S., Gulino Alessandro, Belmonte Beatrice, Montalto Giuseppe, McCubrey James A., New landscapes and horizons in hepatocellular carcinoma therapy, Aging, 12, 3, 2020. Crossref

  16. Ferreira Wallax Augusto Silva, Pinheiro Danilo do Rosário, Costa Junior Carlos Antonio da, Rodrigues-Antunes Symara, Araújo Mariana Diniz, Leão Barros Mariceli Baia, Teixeira Adriana Corrêa de Souza, Faro Thamirys Aline Silva, Burbano Rommel Rodriguez, Oliveira Edivaldo Herculano Correa de, Harada Maria Lúcia, Borges Bárbara do Nascimento, An update on the epigenetics of glioblastomas, Epigenomics, 8, 9, 2016. Crossref

  17. Erdeljac Nathalie, Bussmann Kathrin, Schöler Andrea, Hansen Finn K., Gilmour Ryan, Fluorinated Analogues of the Histone Deacetylase Inhibitor Vorinostat (Zolinza): Validation of a Chiral Hybrid Bioisostere, BITE, ACS Medicinal Chemistry Letters, 10, 9, 2019. Crossref

  18. Bartosch Carla, Lopes José Manuel, Jerónimo Carmen, Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs, Epigenomics, 9, 6, 2017. Crossref

  19. Zhao Haijun, Jiang Yuelong, Lin Fusheng, Zhong Mengya, Tan Jinshui, Zhou Yong, Liu Long, Li Guowei, Deng Manman, Xu Bing, Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells, Experimental Hematology & Oncology, 11, 1, 2022. Crossref

  20. Pinkerneil Maria, Hoffmann Michèle J., Deenen René, Köhrer Karl, Arent Tanja, Schulz Wolfgang A., Niegisch Günter, Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms, Molecular Cancer Therapeutics, 15, 2, 2016. Crossref

  21. Liu Danhui, Liu Yuzhen, Qi Bo, Gu Chengwei, Huo Shuhua, Zhao Baosheng, Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2‐dependent pathway, Cancer Medicine, 10, 15, 2021. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain